Mentions
Extended reach
Total likes
Video views
AI synopsis
The discussions show strong agreement with the article's findings, with users citing examples such as the meta-analysis showing mood improvements up to 60 days, and emphasizing the therapeutic potential with words like 'promising' and 'game changer.' The tone and choice of words reflect high interest and belief in the importance of these findings for future mental health practices.
Most discussions express strong support for the findings, emphasizing the positive therapeutic potential of psychedelics.
The posts demonstrate high curiosity, highlighting meta-analyses, key studies, and the significance of the results.
Many discussions include detailed references to specific studies, effect sizes, and methodological considerations, indicating deep engagement.
There is broad consensus that this research could have a transformative effect on mental health treatment, underscored by phrases like 'promising data' and 'significant effects.'
The first in-depth #psychedelics meta-analysis for #depression & negative #mood state. We found very promising data... Further robust research still needing to occur, with application within a psychotherapeutic framework & adequate medical oversight @MAPS https://t.co/7EtYENJL6j
Psychedelics can improve mood in both healthy subjects and patients with mood disorders. The improved mood was observed in healthy subjects immediately after use and lasted up to 60 days. Depression was acutely alleviated in those with mood disorders. https://t.co/inOuMar6ZS
For patients with mood disorder, significant effect sizes were detected on the acute, medium (2–7 days after treatment) & longer-term outcomes favoring psychedelics on the reduction of depressive symptoms. (one problem: blinding with #psychedelics) https://t.co/BywXeQI3Wl
Latest meta-analysis of the small sample studies on how psychedelic's impact depression. Still finds such drugs have positive effects. But the data is still of low quality. https://t.co/hR8pEgf4Ld
Meta-analytic review of classic serotonergic psychedelics found significant effect sizes for the acute, medium (2–7 days after treatment), and longer-term outcomes favoring psychedelics over placebo on the reduction of depressive symptoms. https://t.co/lntmvyLYTd https://t.co/9Ed3SX7vJv
Patients with & without mood disorders can benefit from psychedelics. Healthy volunteers benefit from psychedelics both acutely and in the long-term. Patients with mood disorders report alleviation of depression both acutely and in the long-term. https://t.co/inOuMar6ZS
The Monster Monday Monster Cast discusses therapeutic effects of serotonergic psychedelics like psilocybin, LSD, and ayahuasca on mood and depression. The show features segments on media, sports, and psychedelic…
This review discusses the use of psychedelics in mental health treatment, highlighting significant improvements in mood and depression symptoms observed in recent studies, especially in mood disorder patients. The…
Meta-analyses on effects + therapy: psilocybin, LSD, ayahuasca on mood disorders and depression https://t.co/BvhscQqdyx psilocybin on anxiety and depression https://t.co/8472mNCDAN psilocybin, ayahuasca, LSD on depression https://t.co/H5odtsz2pC
@armerner_psych One of these? https://t.co/6pF0gxsCFu https://t.co/T2FnJgEdLR https://t.co/y5A4fTeHKm https://t.co/tpssDRcE89 https://t.co/7ZMoPwSRas
2021. Metanálise de 12 estudos clínicos controlados e randomizados sobre uso de psicodélicos serotoninergicos clássicos no tratamento de sintomas depressivos. Apesar da amostra total ser pequena, todos os estudos evidenciaram boa resposta terapêutica. https://t.co/2b4FfdbKoC
First meta-analytic review evaluating the clinical effects of classic #serotonergic #psychedelics vs #placebo for #mood disorders.https://t.co/vR8JXXldqA #nursepractitioner #mentalhealth #psychiatry #medicine #primarycare #depression #mhchat #mh #Psilocybin
We didn't include studies with healthy (non-depressed) participants which usually are done first as open-label Two of the best-known psilocybin studies (Griffiths et al 2006, Hasler et al 2004) are thus not included For all notable psi studies https://t.co/vIIR5m59tc 3/8
Resources: [1] https://t.co/YQTyjoHxBR; https://t.co/wAjw5lSkxQ [2] https://t.co/1acKtIejWJ
RT @TatumPsych: Classic serotonergic psychedelics for mood and depressive symptoms: a meta-analysis of mood disorder patients and h… https:…
Classic serotonergic psychedelics for mood and depressive symptoms: a meta-analysis of mood disorder patients and h… https://t.co/zVgNZ5rgqs
RT @ViewsOnDrugsBot: Classic #serotonergic #psychedelics for mood and depressive symptoms: a #meta-analysis of mood disorder patients and h…
Classic serotonergic psychedelics for mood and depressive symptoms: a meta-analysis of mood disorder patients and healthy participants https://t.co/fAqZd2I9xX
RT @Sean__Last: Latest meta-analysis of the small sample studies on how psychedelic's impact depression. Still finds such drugs have positi…
RT @Sean__Last: Latest meta-analysis of the small sample studies on how psychedelic's impact depression. Still finds such drugs have positi…
Latest meta-analysis of the small sample studies on how psychedelic's impact depression. Still finds such drugs have positive effects. But the data is still of low quality. https://t.co/hR8pEgf4Ld
RT @drugSciBot: Classic #serotonergic #psychedelics for mood and depressive symptoms: a #meta-analysis of mood disorder patients and health…
RT @drugSciBot: Classic #serotonergic #psychedelics for mood and depressive symptoms: a #meta-analysis of mood disorder patients and health…
Classic #serotonergic #psychedelics for mood and depressive symptoms: a #meta-analysis of mood disorder patients and healthy participants https://t.co/lC5seGlPxC
https://t.co/8RVvBP2qlq Artigo sobre o uso de psicodélicos (LSD, Ayuhasca e cogumelos) em psicoterapia assistida e a eficácia pra depressão e transtornos psilogicos ❤️❤️❤️❤️❤️❤️
Patients with & without mood disorders can benefit from psychedelics. Healthy volunteers benefit from psychedelics both acutely and in the long-term. Patients with mood disorders report alleviation of depression both acutely and in the long-term. https://t.co/inOuMar6ZS
RT @drmikehart: Psychedelics can improve mood in both healthy subjects and patients with mood disorders. The improved mood was observed i…
RT @drmikehart: Psychedelics can improve mood in both healthy subjects and patients with mood disorders. The improved mood was observed i…
RT @drmikehart: Psychedelics can improve mood in both healthy subjects and patients with mood disorders. The improved mood was observed i…
RT @drmikehart: Psychedelics can improve mood in both healthy subjects and patients with mood disorders. The improved mood was observed i…
RT @drmikehart: Psychedelics can improve mood in both healthy subjects and patients with mood disorders. The improved mood was observed i…
RT @drmikehart: Psychedelics can improve mood in both healthy subjects and patients with mood disorders. The improved mood was observed i…
RT @drmikehart: Psychedelics can improve mood in both healthy subjects and patients with mood disorders. The improved mood was observed i…
Psychedelics can improve mood in both healthy subjects and patients with mood disorders. The improved mood was observed in healthy subjects immediately after use and lasted up to 60 days. Depression was acutely alleviated in those with mood disorders. https://t.co/inOuMar6ZS
RT @Peter_Grinspoon: For patients with mood disorder, significant effect sizes were detected on the acute, medium (2–7 days after treatment…
First meta-analytic review evaluating the clinical effects of classic serotonergic psychedelics vs placebo for mood state and symptoms of depression https://t.co/D2aDIOFLfY
For patients with mood disorder, significant effect sizes were detected on the acute, medium (2–7 days after treatment) & longer-term outcomes favoring psychedelics on the reduction of depressive symptoms. (one problem: blinding with #psychedelics) https://t.co/BywXeQI3Wl
Classic serotonergic psychedelics for mood and depressive symptoms: a meta-analysis of mood disorder patients and healthy participants https://t.co/GxhKAdPpp2 https://t.co/O9c3nJ5i9A
The abstract of this free full-text paper reads: "Rationale Major depressive disorder is one of the leading global causes of disability, for which the classic serotonergic psychedelics have recently reemerged as a potential therapeutic treatment option. https://t.co/cSO6nFJBNM https://t.co/GnKY5r3IZl
La revisión metaanalítica de los psicodélicos clásicos encontró el tamaño de los efectos significativos para los resultados agudos, medios (2 a 7 días después del tratamiento) y a largo plazo sobre el placebo en la reducción de los síntomas depresivos.
RT @Chacruna_net: Meta-analytic review of classic serotonergic psychedelics found significant effect sizes for the acute, medium (2–7 days…
RT @Chacruna_net: Meta-analytic review of classic serotonergic psychedelics found significant effect sizes for the acute, medium (2–7 days…
Meta-analytic review of classic serotonergic psychedelics found significant effect sizes for the acute, medium (2–7 days after treatment), and longer-term outcomes favoring psychedelics over placebo on the reduction of depressive symptoms. https://t.co/lntmvyLYTd https://t.co/9Ed3SX7vJv
RT @YockeyAndrew: Classic serotonergic psychedelics for mood and depressive symptoms: a meta-analysis of mood disorder patients and healthy…
RT @YockeyAndrew: Classic serotonergic psychedelics for mood and depressive symptoms: a meta-analysis of mood disorder patients and healthy…
Classic serotonergic psychedelics for mood and depressive symptoms: a meta-analysis of mood disorder patients and healthy participants | SpringerLink https://t.co/aFYIfQWRc0
RT @UpToPhate: Classic serotonergic psychedelics for mood and depressive symptoms: a meta-analysis of mood disorder patients and healthy pa…
Classic serotonergic psychedelics for mood and depressive symptoms: a meta-analysis of mood disorder patients and healthy participants. https://t.co/Lvxq6hTh6e
RT @drugSciBot: Classic #serotonergic #psychedelics for mood and depressive symptoms: a #meta-analysis of mood disorder patients and health…
RT @drugSciBot: Classic #serotonergic #psychedelics for mood and depressive symptoms: a #meta-analysis of mood disorder patients and health…
Classic #serotonergic #psychedelics for mood and depressive symptoms: a #meta-analysis of mood disorder patients and healthy participants https://t.co/t6Q9PTddAg
RT @JeromeSarris: The first in-depth #psychedelics meta-analysis for #depression & negative #mood state. We found very promising data... Fu…
See which 12 studies were included and learn more about what this study concluded on our website https://t.co/vIIR5m59tc
This meta-analytic review (2021, n=257) found that psychedelics provide improvements in mood for patients with mood disorders, both short (3h to 1d) and long-term (up to 60 days). https://t.co/4seWaHiLcK
RT @JeromeSarris: The first in-depth #psychedelics meta-analysis for #depression & negative #mood state. We found very promising data... Fu…
RT @JeromeSarris: The first in-depth #psychedelics meta-analysis for #depression & negative #mood state. We found very promising data... Fu…
RT @APRA_bot: Classic serotonergic psychedelics for mood and depressive symptoms: a meta-analysis of mood disorder patients and healthy par…
RT @APRA_bot: Classic serotonergic psychedelics for mood and depressive symptoms: a meta-analysis of mood disorder patients and healthy par…
Classic serotonergic psychedelics for mood and depressive symptoms: a meta-analysis of mood disorder patients and healthy participants. https://t.co/Zas5ONeMDJ
RT @JeromeSarris: The first in-depth #psychedelics meta-analysis for #depression & negative #mood state. We found very promising data... Fu…
RT @JeromeSarris: The first in-depth #psychedelics meta-analysis for #depression & negative #mood state. We found very promising data... Fu…
RT @JeromeSarris: The first in-depth #psychedelics meta-analysis for #depression & negative #mood state. We found very promising data... Fu…
RT @JeromeSarris: The first in-depth #psychedelics meta-analysis for #depression & negative #mood state. We found very promising data... Fu…
The first in-depth #psychedelics meta-analysis for #depression & negative #mood state. We found very promising data... Further robust research still needing to occur, with application within a psychotherapeutic framework & adequate medical oversight @MAPS https://t.co/7EtYENJL6j
New Research: Classic serotonergic psychedelics for mood and depressive symptoms: a meta-analysis of mood disorder patients and healthy participants https://t.co/3x8Ce0YNO6
Classic serotonergic psychedelics for mood and depressive symptoms: a meta-analysis of mood disorder patients and healthy participants https://t.co/ndS9oX3uN3
doi:10.1007/s00213-020-05719-1 [PubMed: 33427944] 3. COMPASS Pathways. COMPASS Pathways announces positive topline results from groundbreaking phase IIb ...
doi:10.1007/s00213-020-05719-1 81. doi:10.1002/sim.2688 23 Dos Santos RG, Osório FL, Crippa JA, Riba J, Zuardi AW, 48 Tendal B, Nüesch E, Higgins JP, Jüni P ...
https://doi.org/10.1007/s00213-020-05719-1. Gasser, Peter MD*; Holstein, Dominique PhD†; Michel, Yvonne PhD‡;. Doblin, Rick PhD§; Yazar-Klosinski, Berra PhD ...
springer.com/article/10.1007/s00213-020-05719-1; • Psychedelics and Neuroplasticity: A Systematic Review Unraveling the Biological ...
JS
MD
GD
SL
CI
A
BW
PN
PM
B
F
S
TC
VD
AA
D
NS
K
JC
TB
TN
MP
HD
CC
PD
AC
D
PN
CL
JF
T
DZ
AH
U
LP
MG
MB
MH
MM
AM
JB
DC
PA
PC